Published in:
Open Access
01-12-2012 | Research
Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
Authors:
Tianhai Ji, Dan Liu, Wei Shao, Wensheng Yang, Haiqiao Wu, Xiuwu Bian
Published in:
Journal of Experimental & Clinical Cancer Research
|
Issue 1/2012
Login to get access
Abstract
Background
LATS1 is a tumor suppressor genes implicated in the pathogenesis of certain types of tumors, but its role is not known in human glioma.
Methods
Using real-time PCR and immunohistochemistry, we detected the mRNA and protein expression of LATS1 in glioma. The effect of LATS1 on cell growth and invasion were investigated.
Results
We found that mRNA and protein of LATS1 expression is significantly downregulated in glioma compared with normal control brain tissues. Furthermore, reduced LATS1 expression was markedly negatively correlated with WHO grade and KPS (p<0.001 and p<0.001) in glioma patients. Patients with lower LATS1 expression had a significantly shorter overall survival time than did patients with higher LATS1 expression. Multivariate analysis suggested that the level of LATS1 expression was an independent prognostic indicator (p<0.001) for the survival of patients with glioma. Forced expression of LATS1 in glioma U251 cells not only significantly suppressed cell growth, migration and invasion, but retarded cell cycle progression from G2/M to G1 in vitro. Finally, we found that overexpressed LATS1 markedly inhibited the expression level of cell cycle factor CCNA1.
Conclusion
These results indicate that LATS1 is an important candidate tumor suppressor and its downregulated expression may contribute to glioma progression.